New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
13:01 EDTAAgilent enters strategic partnership with Sera Prognostics
Agilent Technologies (A) and Sera Prognostics Inc., a women's health company, announced a strategic partnership to develop proteomic assays for the early prediction of pregnancy complications. Sera Prognostics is currently developing a novel test for the early prediction of preterm birth risk using advanced proteomic science. Agilent is a leading provider of a wide range of analytical instrumentation, including liquid chromatography, mass spectrometry and automation systems. As part of the partnership, Sera Prognostics purchased multiple Agilent 1290 Infinity ultra high-performance liquid chromatography systems, 6490 iFunnel triple quadrupole mass spectrometry systems and 1260 Infinity LC systems with ultraviolet detectors and is adapting Agilent's automated sample-preparation technologies for production. The partners will develop high-throughput workflows for sample preparation and mass-spectrometry analysis. To meet the demands of high-volume testing, Sera Prognostics expects to leverage Agilent's novel automated sample-prep technology and other automation, including the AssayMAP Bravo and RapidFire fast liquid chromatography together with ultra-sensitive ion funnel triple quadrupole mass spectrometry.
News For A From The Last 14 Days
Check below for free stories on A the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
11:01 EDTAAgilent signs co-marketing agreement with MRM Proteomics
Subscribe for More Information
July 17, 2014
06:20 EDTAAgilent initiated with a Neutral at Citigroup
Target $64.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use